- Headquarters
- Sydney
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- baymatob.com
- Total Funding
- $14.3M
- Last Round
- $6.5M Series AMay 2026
- Rounds
- 5
About
Baymatob develops Oli, a wireless wearable maternal and fetal monitoring platform powered by AI. Oli captures physiological data via ten biosensors to identify postpartum hemorrhage risk before birth. The device has received FDA Breakthrough Device Designation.
Summary
Baymatob is a Femtech company based in Sydney, Australia, founded in 2017. It has raised $14.3M in total across 5 rounds, most recently a $6.5M Series A round in May 2026. Investors include Scale Investors.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2026
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Level 0 Health is creating the new default for hormone measurement and tracking.
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
Healthcare AI platform that converts patient-clinician conversations into structured clinical not...
OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...
Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Largest national, virtual, in-network psychiatry practice